Dr. Reddy’s Laboratories has announced the transfer of promoter shares totaling 17,17,26,540 equity shares, or 20.58%, to VSD Family Trust and GVP Family Trust through an off-market transaction. This transfer, effective September 17, 2025, is part of a private family arrangement for succession planning. Post-transfer, there is no change in the total shareholding of the promoters.
Promoter Share Transfer Details
Dr. Reddy’s Laboratories Limited has disclosed an off-market transfer of shares by promoters to family trusts. The total number of shares transferred amounts to 17,17,26,540 equity shares, each with a face value of ₹1. This represents 20.58% of the company’s equity.
Transfer Breakdown
The transfer occurred on September 17, 2025, and was structured as follows:
- 7,56,30,620 equity shares (9.06%) were transferred by Satish Reddy Kallam to VSD Family Trust.
- 9,60,95,920 equity shares (11.51%) were transferred by G V Prasad to GVP Family Trust.
Purpose of the Transfer
This transfer is characterized as a private family arrangement aimed at facilitating smooth succession planning and streamlining the family’s assets and business interests. The shares were acquired by the trusts from the promoters under an exemption provided in a SEBI Order dated December 31, 2024.
Impact on Shareholding
The company clarified that the transaction does not alter the overall shareholding of the promoter group in Dr. Reddy’s Laboratories. The transfer is purely an internal restructuring within the promoter’s family framework.
Source: BSE
